3769 — GMO Payment Gateway Balance Sheet
0.000.00%
- ¥685bn
- ¥552bn
- ¥74bn
- 96
- 22
- 99
- 86
Annual balance sheet for GMO Payment Gateway, fiscal year end - September 30th, JPY millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 96,044 | 82,049 | 122,255 | 128,228 | 174,762 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 34,367 | 35,202 | 44,296 | 52,349 | 58,599 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 169,380 | 189,503 | 244,257 | 258,467 | 298,096 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 3,715 | 3,949 | 3,542 | 3,354 | 3,921 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 192,023 | 215,456 | 273,407 | 292,347 | 344,702 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 136,170 | 132,715 | 147,820 | 163,290 | 204,361 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 160,288 | 159,610 | 186,284 | 200,072 | 241,807 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 31,734 | 55,846 | 87,123 | 92,274 | 102,895 |
Total Liabilities & Shareholders' Equity | 192,023 | 215,456 | 273,407 | 292,347 | 344,702 |
Total Common Shares Outstanding |